CAS 1388651-30-6

Elenbecestat

CAS : 1388651-30-6

Elenbecestat (E2609) is an effective oral bioutilization and CNS penetrating ACE-1 inhibitor for the treatment of Alzheimer's disease.

Formule : C₁₉H₁₈F₃N₅O₂S

Degré de pureté : 99.95%

Couleur et forme : Solid

Masse moléculaire : 437.44

Ref: TM-T11175

Elenbecestat

CAS : 1388651-30-6

Elenbecestat

Degré de pureté : ≥98%

Masse moléculaire : 437.44g/mol

Ref: 54-BUP09627

Elenbecestat

CAS : 1388651-30-6

Elenbecestat is a monoclonal antibody that inhibits the enzyme acetylcholinesterase (AChE), which degrades the neurotransmitter acetylcholine. Elenbecestat has been shown to be effective in reducing insulin resistance and improving glucose tolerance in mice. Clinical trials have shown that elenbecestat is safe for use in humans, with few side effects. Elenbecestat has also been shown to reduce fatty acids and protofibril formation in vitro. It also acts as an esterase inhibitor, preventing the hydrolysis of phospholipids. This drug may cause allergic reactions.

Formule : C₁₉H₁₈F₃N₅O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 437.44 g/mol

Ref: 3D-NFC65130